M
Michael J. Burns
Researcher at Boston College
Publications - 142
Citations - 4465
Michael J. Burns is an academic researcher from Boston College. The author has contributed to research in topics: Plasmon & Solar cell. The author has an hindex of 31, co-authored 140 publications receiving 4146 citations. Previous affiliations of Michael J. Burns include Harvard University & California Institute of Technology.
Papers
More filters
Journal ArticleDOI
Heavy Metal Content of Ayurvedic Herbal Medicine Products
Robert B. Saper,Stefanos N. Kales,Janet Paquin,Michael J. Burns,David Eisenberg,Roger B. Davis,Russell S. Phillips +6 more
TL;DR: One of 5 Ayurvedic HMPs produced in South Asia and available in Boston South Asian grocery stores contains potentially harmful levels of lead, mercury, and/or arsenic, which may put users at risk for heavy metal toxicity.
Journal ArticleDOI
In Vivo Observation of Cavitation and Embolism Repair Using Magnetic Resonance Imaging
TL;DR: Measurements demonstrate that MRI can be used to monitor the functional status of individual xylem vessels, providing the first method to study the process of cavitation and embolism repair in intact plants.
Journal ArticleDOI
Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma
Maurizio Zangari,Dixie-Lee Esseltine,Choon-Kee Lee,Bart Barlogie,Francesca Elice,Michael J. Burns,Seung-Hee Kang,Shmuel Yaccoby,Kevin Najarian,Paul G. Richardson,Pieter Sonneveld,Guido Tricot +11 more
TL;DR: The prompt response to bortezomib observed in a 63‐year‐old woman with multiple myeloma was associated with a significant increase in alkaline phosphatase (ALP), suggesting that response to Bortzomib in Myeloma is closely associated with osteoblastic activation.
Journal Article
Genetic determinants of malignancy in a mouse model for oligodendroglioma.
William A. Weiss,Michael J. Burns,Christopher S. Hackett,Kenneth Aldape,John R. Hill,John R. Hill,Hiroko Kuriyama,Nagato Kuriyama,Nadezhda Milshteyn,Timothy P.L. Roberts,Michael F. Wendland,Ron DePinho,Mark A. Israel,Mark A. Israel +13 more
TL;DR: These models hold promise for studying tumor lineage, identifying contributing genetic alterations and evaluating preclinical therapies in this important neoplasm, and p53 pathway mutations can mediate the transition from low to high grade.
Journal ArticleDOI
A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning.
TL;DR: Physostigmine is more effective and safer than benzodiazepines for the treatment of anticholinergic agitation and delirium and a prospective controlled study is necessary to confirm such findings.